Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.79 is 83% above its 5-year average of -4.78, near the high end of its 5-year range (-10.93–-0.48).
5.95% above its 12-month average of -0.84.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.20.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.79
EARNINGS PER SHARE (EPS) AVG TTM
-0.84
EARNINGS PER SHARE (EPS) AVG 3Y
-2.55
EARNINGS PER SHARE (EPS) AVG 5Y
-4.78
EARNINGS PER SHARE (EPS) AVG 10Y
-10.82
EARNINGS PER SHARE (EPS) AVG 15Y
-18.93
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+5.95%
CURRENT VS 3Y AVG
+69.08%
CURRENT VS 5Y AVG
+83.47%
CURRENT VS 10Y AVG
+92.70%
CURRENT VS 15Y AVG
+95.83%
CURRENT VS 20Y AVG
N/A
Dare Bioscience, Inc.
Market Cap
$12.51M
Earnings Per Share (EPS)
-0.79
TTM Avg
-0.84
3Y Avg
-2.55
5Y Avg
-4.78
Market Cap
$12.54M
Earnings Per Share (EPS)
-4.56
TTM Avg
-22.43
3Y Avg
-71.26
5Y Avg
-107.32
Market Cap
$12.43M
Earnings Per Share (EPS)
-4.48
TTM Avg
-3.92
3Y Avg
-3.23
5Y Avg
-105.55
Market Cap
$12.31M
Earnings Per Share (EPS)
-1.62
TTM Avg
-966.25
3Y Avg
-483.82
5Y Avg
-322.89
Market Cap
$12.29M
Earnings Per Share (EPS)
-0.47
TTM Avg
-0.74
3Y Avg
-0.71
5Y Avg
-0.50
Market Cap
$12.77M
Earnings Per Share (EPS)
-5.75
TTM Avg
-5.10
3Y Avg
-9.55
5Y Avg
-8.93
Market Cap
$12.12M
Earnings Per Share (EPS)
-0.20
TTM Avg
-0.26
3Y Avg
-0.46
5Y Avg
-0.44
Market Cap
$13.08M
Earnings Per Share (EPS)
-11.33
TTM Avg
-17.89
3Y Avg
-30.77
5Y Avg
-41.73
Market Cap
$13.20M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dare Bioscience, Inc. (DARE) | $12.51M | -0.79 | -0.84 | -2.55 | -4.78 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.54M | -4.56 | -22.43 | -71.26 | -107.32 |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.43M | -4.48 | -3.92 | -3.23 | -105.55 |
| Lantern Pharma Inc. (LTRN)vs › | $12.31M | -1.62 | -966.25 | -483.82 | -322.89 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.29M | -0.47 | -0.74 | -0.71 | -0.50 |
| Cytosorbents Corporation (CTSO)vs › | $12.77M | -5.75 | -5.10 | -9.55 | -8.93 |
| IRIDEX Corporation (IRIX)vs › | $12.12M | -0.20 | -0.26 | -0.46 | -0.44 |
| Passage Bio, Inc. (PASG)vs › | $13.08M | -11.33 | -17.89 | -30.77 | -41.73 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -2.11 | -3.38 | -4.90 | -6.31 |
| Biofrontera Inc. (BFRI)vs › | $11.76M | -0.60 | -2.13 | -4.47 | -13.49 |
Trailing EPS (TTM)
$-0.79
Forward EPS (Est.)
$-0.78
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.20 |
| 2024-12-31 | -0.48 |
| 2023-12-31 | -4.15 |
| 2022-12-31 | -4.39 |
| 2021-12-31 | -7.52 |
| 2020-12-31 | -10.93 |
| 2019-12-31 | -10.99 |
| 2018-12-31 | -30.16 |
| 2017-12-31 | -3.56 |
| 2016-12-31 | -30.02 |
| 2015-12-31 | -15.57 |
| 2014-12-31 | -192.00 |
| 2013-12-31 | -108.19 |
| 2012-12-31 | -280.83 |
| 2011-12-31 | -267.41 |
